PR Newswire Article CALGARY, AB. and BATON ROUGE, La., Aug. 11, 2021 /PRNewswire/ — Skymount Medical, a drug discovery company, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies, known as SM-19, for COVID-19 patients. In vitro (cell) and in … Read More

NewsFileCorp Article Vancouver, British Columbia–(Newsfile Corp. – December 31, 2020) – iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”), iCo Therapeutics, Inc. (“iCo”) and Skymount Medical, Inc. (“Skymount”) announced today that they have entered into a non-binding Memorandum … Read More

ISU EDU Article Artificial intelligence software developed by an interdisciplinary team of LSU researchers could shorten the time for drug development from 15 years to 15 days; save lives, reduce symptoms. BATON ROUGE, June 5, 2020 — A Calgary-based technology company, Skymount … Read More